George Tidmarsh, the newly installed director of the FDA’s Center for Drug Evaluation and Research, was placed on leave ...
Dr. George Tidmarsh was placed on administrative leave for an allegation he has denied, claiming the move is in retaliation ...
D r. George Tidmarsh, the FDA drug regulator who was placed on leave and complained of a “toxic” work environment in an ...
20hon MSN
FDA’s top drug regulator resigns after federal officials probe ‘serious concerns’ about his conduct
Dr. George Tidmarsh, the head of the Food and Drug Administration’s drug center, abruptly resigned Sunday amid concerns about ...
The U.S. Food and Drug Administration recalled more than 580,000 bottles of a blood pressure medication. Is your medication ...
It was the latest shockwave to sweep through an agency beset by all kinds of tumult in recent months. In interviews, ...
The Food and Drug Administration (FDA) just announced that over 580,000 bottles of blood pressure medications made by Teva ...
“The FDA is aware of reports of serious complications such as burns, scarring, fat loss, disfigurement, and nerve damage, ...
Compass Pathways, which is developing a psilocybin treatment for severe depression, said it now expects an earlier decision ...
Two more people have died and several others have been hospitalized in connection with a listeria outbreak linked to recalled ...
In any review of mifepristone, the FDA will now have to grapple with Judge Otake’s conclusion that the 2023 REMS decision for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback